InvestorsHub Logo
Post# of 251938
Next 10
Followers 14
Posts 3812
Boards Moderated 1
Alias Born 07/07/2002

Re: DewDiligence post# 247913

Thursday, 12/14/2023 12:58:09 PM

Thursday, December 14, 2023 12:58:09 PM

Post# of 251938
NKGN reorienting their autologous program towards non-cancer diseases. Some intriguing compassionate use results on Alzheimer's but N was low, now expanding to phase 1/2a to see if results can be repeated. Still have allo program for cancer.

https://nkgenbiotech.com/science/#nk-cells-function

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.